Budget Impact Analysis of Niraparib and Olaparub As Maintenance Therapy for Platinum Sensitive, Recurrent Ovarian Cancer In The US
Abstract
Authors
L Wu L Zhong
L Wu L Zhong
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now